

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protoporphyrinogen IX metabolic process (GO:0046501) | 9.82000035 |
| 2 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 7.11751071 |
| 3 | hemoglobin metabolic process (GO:0020027) | 7.09218691 |
| 4 | oxygen transport (GO:0015671) | 7.04784567 |
| 5 | porphyrin-containing compound biosynthetic process (GO:0006779) | 6.98021287 |
| 6 | gas transport (GO:0015669) | 6.46143034 |
| 7 | erythrocyte maturation (GO:0043249) | 6.28546021 |
| 8 | erythrocyte development (GO:0048821) | 6.26832761 |
| 9 | regulation of RNA export from nucleus (GO:0046831) | 6.04981288 |
| 10 | tetrapyrrole biosynthetic process (GO:0033014) | 6.01851938 |
| 11 | porphyrin-containing compound metabolic process (GO:0006778) | 5.87268989 |
| 12 | heme biosynthetic process (GO:0006783) | 5.54970095 |
| 13 | regulation of nucleobase-containing compound transport (GO:0032239) | 4.89055783 |
| 14 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 4.74020924 |
| 15 | heme metabolic process (GO:0042168) | 4.59099347 |
| 16 | myeloid cell development (GO:0061515) | 4.35542849 |
| 17 | nuclear pore complex assembly (GO:0051292) | 4.25185307 |
| 18 | definitive hemopoiesis (GO:0060216) | 4.13220698 |
| 19 | regulation of response to osmotic stress (GO:0047484) | 4.01754942 |
| 20 | mitotic chromosome condensation (GO:0007076) | 4.00706176 |
| 21 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.90228868 |
| 22 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.71158000 |
| 23 | megakaryocyte development (GO:0035855) | 3.68659598 |
| 24 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.66232054 |
| 25 | embryonic process involved in female pregnancy (GO:0060136) | 3.64267824 |
| 26 | Golgi transport vesicle coating (GO:0048200) | 3.59182462 |
| 27 | COPI coating of Golgi vesicle (GO:0048205) | 3.59182462 |
| 28 | response to arsenic-containing substance (GO:0046685) | 3.58130592 |
| 29 | erythrocyte differentiation (GO:0030218) | 3.52401417 |
| 30 | modulation by symbiont of host cellular process (GO:0044068) | 3.50005380 |
| 31 | cellular response to virus (GO:0098586) | 3.49856505 |
| 32 | modulation by virus of host process (GO:0019054) | 3.42139535 |
| 33 | nuclear pore organization (GO:0006999) | 3.38200871 |
| 34 | tetrapyrrole metabolic process (GO:0033013) | 3.38132435 |
| 35 | DNA topological change (GO:0006265) | 3.32925209 |
| 36 | granulocyte differentiation (GO:0030851) | 3.23108482 |
| 37 | iron ion import (GO:0097286) | 3.19279988 |
| 38 | mitochondrial fusion (GO:0008053) | 3.14337886 |
| 39 | response to methylmercury (GO:0051597) | 3.12653830 |
| 40 | platelet formation (GO:0030220) | 3.11139682 |
| 41 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.06872177 |
| 42 | protein localization to endosome (GO:0036010) | 3.03085367 |
| 43 | hepatocyte apoptotic process (GO:0097284) | 2.99152205 |
| 44 | proline biosynthetic process (GO:0006561) | 2.99074831 |
| 45 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.98935964 |
| 46 | regulation of erythrocyte differentiation (GO:0045646) | 2.96887973 |
| 47 | cellular response to arsenic-containing substance (GO:0071243) | 2.93778656 |
| 48 | pore complex assembly (GO:0046931) | 2.86104684 |
| 49 | glycine transport (GO:0015816) | 2.86063326 |
| 50 | protein targeting to plasma membrane (GO:0072661) | 2.83779151 |
| 51 | RNA stabilization (GO:0043489) | 2.83688773 |
| 52 | mRNA stabilization (GO:0048255) | 2.83688773 |
| 53 | blood vessel maturation (GO:0001955) | 2.82931220 |
| 54 | protein export from nucleus (GO:0006611) | 2.76111986 |
| 55 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.75937893 |
| 56 | positive regulation of protein homooligomerization (GO:0032464) | 2.74690479 |
| 57 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.71686045 |
| 58 | NIK/NF-kappaB signaling (GO:0038061) | 2.71411284 |
| 59 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.70853728 |
| 60 | positive regulation of megakaryocyte differentiation (GO:0045654) | 2.61326149 |
| 61 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.61277589 |
| 62 | regulation of chromatin binding (GO:0035561) | 2.58571258 |
| 63 | DNA unwinding involved in DNA replication (GO:0006268) | 2.58529182 |
| 64 | negative regulation of necroptotic process (GO:0060546) | 2.56240136 |
| 65 | embryonic hemopoiesis (GO:0035162) | 2.56094542 |
| 66 | positive regulation of granulocyte differentiation (GO:0030854) | 2.54213693 |
| 67 | determination of adult lifespan (GO:0008340) | 2.50171851 |
| 68 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 2.44387004 |
| 69 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.44319896 |
| 70 | cellular protein complex localization (GO:0034629) | 2.42703199 |
| 71 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.42067536 |
| 72 | mitotic sister chromatid segregation (GO:0000070) | 2.40313085 |
| 73 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.40223058 |
| 74 | response to insecticide (GO:0017085) | 2.40178661 |
| 75 | endothelium development (GO:0003158) | 2.39292570 |
| 76 | response to lead ion (GO:0010288) | 2.36572833 |
| 77 | dosage compensation (GO:0007549) | 2.34992123 |
| 78 | low-density lipoprotein particle clearance (GO:0034383) | 2.34715643 |
| 79 | protein localization to chromosome, centromeric region (GO:0071459) | 2.33773262 |
| 80 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.33392276 |
| 81 | N-terminal protein amino acid acetylation (GO:0006474) | 2.33314176 |
| 82 | modulation by virus of host morphology or physiology (GO:0019048) | 2.32996217 |
| 83 | DNA replication initiation (GO:0006270) | 2.32753663 |
| 84 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 2.32520535 |
| 85 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.31439076 |
| 86 | pentose-phosphate shunt (GO:0006098) | 2.30699534 |
| 87 | regulation of translational fidelity (GO:0006450) | 2.29778027 |
| 88 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.29080571 |
| 89 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.28555315 |
| 90 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.28400684 |
| 91 | nuclear envelope disassembly (GO:0051081) | 2.26977367 |
| 92 | membrane disassembly (GO:0030397) | 2.26977367 |
| 93 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.26736767 |
| 94 | protein-DNA complex disassembly (GO:0032986) | 2.26363491 |
| 95 | nucleosome disassembly (GO:0006337) | 2.26363491 |
| 96 | mitotic nuclear envelope disassembly (GO:0007077) | 2.25587950 |
| 97 | mitochondrial DNA metabolic process (GO:0032042) | 2.24199410 |
| 98 | regulation of early endosome to late endosome transport (GO:2000641) | 2.23983246 |
| 99 | regulation of histone H3-K27 methylation (GO:0061085) | 2.23727271 |
| 100 | chromosome condensation (GO:0030261) | 2.19925981 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.32891471 |
| 2 | GATA1_22025678_ChIP-Seq_K562_Human | 4.02711115 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.85856378 |
| 4 | GATA1_19941826_ChIP-Seq_K562_Human | 3.60880777 |
| 5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.38636023 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 3.03076233 |
| 7 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.93518176 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.46230830 |
| 9 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.42451101 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.22576496 |
| 11 | GATA2_19941826_ChIP-Seq_K562_Human | 2.15443475 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.10564215 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.04619719 |
| 14 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.99342693 |
| 15 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.97274967 |
| 16 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.87225479 |
| 17 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.85697322 |
| 18 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.84962229 |
| 19 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.82350678 |
| 20 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.76651411 |
| 21 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.73988501 |
| 22 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.72489055 |
| 23 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68628133 |
| 24 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.68083112 |
| 25 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.60776284 |
| 26 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.57538779 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 1.56583515 |
| 28 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.56316417 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.55131584 |
| 30 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.53831176 |
| 31 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.52333449 |
| 32 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.49893786 |
| 33 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.45741914 |
| 34 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.45676303 |
| 35 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.45001822 |
| 36 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.44881582 |
| 37 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.42904289 |
| 38 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.42573651 |
| 39 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.42325872 |
| 40 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.41914513 |
| 41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.41080544 |
| 42 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.37543871 |
| 43 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36378076 |
| 44 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.36029301 |
| 45 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.35957145 |
| 46 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.35845416 |
| 47 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.35588734 |
| 48 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34989172 |
| 49 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.34974310 |
| 50 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.33390006 |
| 51 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.32519908 |
| 52 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.31605695 |
| 53 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.31533960 |
| 54 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.30205922 |
| 55 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.28960153 |
| 56 | ATF3_27146783_Chip-Seq_COLON_Human | 1.28210752 |
| 57 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.27950122 |
| 58 | UTX_26944678_Chip-Seq_JUKART_Human | 1.27230860 |
| 59 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.25909360 |
| 60 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.24871551 |
| 61 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.24258599 |
| 62 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.22807519 |
| 63 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.22402130 |
| 64 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.20834529 |
| 65 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.20480509 |
| 66 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.19932486 |
| 67 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.18553304 |
| 68 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17082194 |
| 69 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.15456979 |
| 70 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.15027308 |
| 71 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.14493224 |
| 72 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.13085896 |
| 73 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.13059829 |
| 74 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.12894938 |
| 75 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.12654128 |
| 76 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.12024745 |
| 77 | MYB_26560356_Chip-Seq_TH1_Human | 1.11893093 |
| 78 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.11620224 |
| 79 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.11586996 |
| 80 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.11255493 |
| 81 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.10652324 |
| 82 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.10471550 |
| 83 | MAF_26560356_Chip-Seq_TH2_Human | 1.10010175 |
| 84 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.09957708 |
| 85 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.08543341 |
| 86 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.05254508 |
| 87 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.01366076 |
| 88 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00487458 |
| 89 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.00189458 |
| 90 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.00128059 |
| 91 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.99818681 |
| 92 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99435038 |
| 93 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.98945545 |
| 94 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.97957611 |
| 95 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97796991 |
| 96 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.96790002 |
| 97 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.96769939 |
| 98 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.96605108 |
| 99 | KDM2B_26808549_Chip-Seq_K562_Human | 0.96155568 |
| 100 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.94048404 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003656_abnormal_erythrocyte_physiolo | 6.84301043 |
| 2 | MP0004147_increased_porphyrin_level | 6.28432866 |
| 3 | MP0005451_abnormal_body_composition | 4.19017995 |
| 4 | MP0005083_abnormal_biliary_tract | 3.58628577 |
| 5 | MP0008260_abnormal_autophagy | 3.00339529 |
| 6 | MP0001545_abnormal_hematopoietic_system | 2.59779316 |
| 7 | MP0005397_hematopoietic_system_phenotyp | 2.59779316 |
| 8 | MP0003303_peritoneal_inflammation | 2.43832200 |
| 9 | MP0005076_abnormal_cell_differentiation | 2.32237796 |
| 10 | MP0003111_abnormal_nucleus_morphology | 2.23809865 |
| 11 | MP0009278_abnormal_bone_marrow | 1.91277598 |
| 12 | MP0002009_preneoplasia | 1.82910109 |
| 13 | MP0004957_abnormal_blastocyst_morpholog | 1.77562910 |
| 14 | MP0004233_abnormal_muscle_weight | 1.74025578 |
| 15 | MP0003693_abnormal_embryo_hatching | 1.72323780 |
| 16 | MP0004808_abnormal_hematopoietic_stem | 1.69776423 |
| 17 | MP0003566_abnormal_cell_adhesion | 1.68859612 |
| 18 | MP0004185_abnormal_adipocyte_glucose | 1.56559349 |
| 19 | MP0002396_abnormal_hematopoietic_system | 1.54203236 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 1.53683552 |
| 21 | MP0010094_abnormal_chromosome_stability | 1.49043412 |
| 22 | MP0002877_abnormal_melanocyte_morpholog | 1.48461106 |
| 23 | MP0002822_catalepsy | 1.46461810 |
| 24 | MP0003221_abnormal_cardiomyocyte_apopto | 1.46405769 |
| 25 | MP0002166_altered_tumor_susceptibility | 1.44018157 |
| 26 | MP0001730_embryonic_growth_arrest | 1.41645643 |
| 27 | MP0003077_abnormal_cell_cycle | 1.40636390 |
| 28 | MP0010307_abnormal_tumor_latency | 1.40593133 |
| 29 | MP0004510_myositis | 1.39491779 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.38967881 |
| 31 | MP0000747_muscle_weakness | 1.37922928 |
| 32 | MP0000685_abnormal_immune_system | 1.36844461 |
| 33 | MP0003191_abnormal_cellular_cholesterol | 1.27816561 |
| 34 | MP0000749_muscle_degeneration | 1.26789227 |
| 35 | MP0002398_abnormal_bone_marrow | 1.26313520 |
| 36 | MP0003984_embryonic_growth_retardation | 1.23239691 |
| 37 | MP0002086_abnormal_extraembryonic_tissu | 1.20304022 |
| 38 | MP0002138_abnormal_hepatobiliary_system | 1.17658696 |
| 39 | MP0002080_prenatal_lethality | 1.16652937 |
| 40 | MP0002088_abnormal_embryonic_growth/wei | 1.16156681 |
| 41 | MP0001672_abnormal_embryogenesis/_devel | 1.15435451 |
| 42 | MP0005380_embryogenesis_phenotype | 1.15435451 |
| 43 | MP0005636_abnormal_mineral_homeostasis | 1.14499812 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.14025000 |
| 45 | MP0004087_abnormal_muscle_fiber | 1.13987488 |
| 46 | MP0000313_abnormal_cell_death | 1.12798150 |
| 47 | MP0010630_abnormal_cardiac_muscle | 1.12336665 |
| 48 | MP0009931_abnormal_skin_appearance | 1.12011091 |
| 49 | MP0002722_abnormal_immune_system | 1.11855365 |
| 50 | MP0005058_abnormal_lysosome_morphology | 1.11449952 |
| 51 | MP0005621_abnormal_cell_physiology | 1.08654779 |
| 52 | MP0001697_abnormal_embryo_size | 1.07283060 |
| 53 | MP0000350_abnormal_cell_proliferation | 1.07021208 |
| 54 | MP0010352_gastrointestinal_tract_polyps | 1.06700181 |
| 55 | MP0003453_abnormal_keratinocyte_physiol | 1.03256214 |
| 56 | MP0000689_abnormal_spleen_morphology | 1.02245444 |
| 57 | MP0002006_tumorigenesis | 1.01243927 |
| 58 | MP0001915_intracranial_hemorrhage | 1.01095306 |
| 59 | MP0003172_abnormal_lysosome_physiology | 1.00508855 |
| 60 | MP0004145_abnormal_muscle_electrophysio | 1.00128698 |
| 61 | MP0003828_pulmonary_edema | 0.99776324 |
| 62 | MP0000465_gastrointestinal_hemorrhage | 0.99517490 |
| 63 | MP0009333_abnormal_splenocyte_physiolog | 0.98036288 |
| 64 | MP0004264_abnormal_extraembryonic_tissu | 0.96798243 |
| 65 | MP0003186_abnormal_redox_activity | 0.96522117 |
| 66 | MP0005501_abnormal_skin_physiology | 0.95754164 |
| 67 | MP0008438_abnormal_cutaneous_collagen | 0.94851042 |
| 68 | MP0002429_abnormal_blood_cell | 0.94674520 |
| 69 | MP0000759_abnormal_skeletal_muscle | 0.92229415 |
| 70 | MP0004036_abnormal_muscle_relaxation | 0.90798321 |
| 71 | MP0005330_cardiomyopathy | 0.90091728 |
| 72 | MP0004084_abnormal_cardiac_muscle | 0.87877940 |
| 73 | MP0004947_skin_inflammation | 0.87604594 |
| 74 | MP0005384_cellular_phenotype | 0.87396023 |
| 75 | MP0003763_abnormal_thymus_physiology | 0.87181678 |
| 76 | MP0003950_abnormal_plasma_membrane | 0.86483194 |
| 77 | MP0002269_muscular_atrophy | 0.86453517 |
| 78 | MP0000703_abnormal_thymus_morphology | 0.86426211 |
| 79 | MP0009840_abnormal_foam_cell | 0.83882458 |
| 80 | MP0008004_abnormal_stomach_pH | 0.82934803 |
| 81 | MP0002019_abnormal_tumor_incidence | 0.82890961 |
| 82 | MP0003091_abnormal_cell_migration | 0.81974409 |
| 83 | MP0002332_abnormal_exercise_endurance | 0.81117343 |
| 84 | MP0009697_abnormal_copulation | 0.79786617 |
| 85 | MP0006138_congestive_heart_failure | 0.77466496 |
| 86 | MP0008775_abnormal_heart_ventricle | 0.76094884 |
| 87 | MP0000609_abnormal_liver_physiology | 0.72046113 |
| 88 | MP0001727_abnormal_embryo_implantation | 0.70715203 |
| 89 | MP0000490_abnormal_crypts_of | 0.69104822 |
| 90 | MP0005666_abnormal_adipose_tissue | 0.68051331 |
| 91 | MP0000598_abnormal_liver_morphology | 0.67690876 |
| 92 | MP0000266_abnormal_heart_morphology | 0.66957561 |
| 93 | MP0000750_abnormal_muscle_regeneration | 0.66922616 |
| 94 | MP0008995_early_reproductive_senescence | 0.66213389 |
| 95 | MP0002106_abnormal_muscle_physiology | 0.65919758 |
| 96 | MP0000358_abnormal_cell_content/ | 0.64324472 |
| 97 | MP0001529_abnormal_vocalization | 0.63907216 |
| 98 | MP0004130_abnormal_muscle_cell | 0.63871509 |
| 99 | MP0000858_altered_metastatic_potential | 0.63143513 |
| 100 | MP0009384_cardiac_valve_regurgitation | 0.62568156 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 8.84286261 |
| 2 | Poikilocytosis (HP:0004447) | 7.06652918 |
| 3 | Reticulocytosis (HP:0001923) | 6.76389347 |
| 4 | Cholelithiasis (HP:0001081) | 4.73872306 |
| 5 | Abnormality of reticulocytes (HP:0004312) | 4.55634418 |
| 6 | Polycythemia (HP:0001901) | 4.35185205 |
| 7 | Microcytic anemia (HP:0001935) | 4.29289136 |
| 8 | Abnormal gallbladder morphology (HP:0012437) | 4.16393416 |
| 9 | Hypochromic microcytic anemia (HP:0004840) | 3.92533006 |
| 10 | Abnormal gallbladder physiology (HP:0012438) | 3.85080227 |
| 11 | Cholecystitis (HP:0001082) | 3.85080227 |
| 12 | Paralysis (HP:0003470) | 3.84731943 |
| 13 | Acanthocytosis (HP:0001927) | 3.79365213 |
| 14 | Ileus (HP:0002595) | 3.24011767 |
| 15 | Abnormal hemoglobin (HP:0011902) | 3.16659028 |
| 16 | Abnormality of the fingertips (HP:0001211) | 3.08351706 |
| 17 | Abnormality of the gallbladder (HP:0005264) | 3.07135676 |
| 18 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.07027515 |
| 19 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.05850989 |
| 20 | Hyperbilirubinemia (HP:0002904) | 3.01874865 |
| 21 | Diaphragmatic weakness (HP:0009113) | 2.93760552 |
| 22 | Increased connective tissue (HP:0009025) | 2.92321278 |
| 23 | Insomnia (HP:0100785) | 2.90852368 |
| 24 | Hypochromic anemia (HP:0001931) | 2.86098959 |
| 25 | Hypertensive crisis (HP:0100735) | 2.71170424 |
| 26 | Abnormality of iron homeostasis (HP:0011031) | 2.51029493 |
| 27 | Exercise-induced myalgia (HP:0003738) | 2.46726698 |
| 28 | Distal lower limb amyotrophy (HP:0008944) | 2.42215301 |
| 29 | Cellulitis (HP:0100658) | 2.40792314 |
| 30 | Progressive muscle weakness (HP:0003323) | 2.38059296 |
| 31 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.36328365 |
| 32 | Hemorrhage of the eye (HP:0011885) | 2.36163503 |
| 33 | Myopathic facies (HP:0002058) | 2.35853052 |
| 34 | Nemaline bodies (HP:0003798) | 2.35477143 |
| 35 | Rhabdomyolysis (HP:0003201) | 2.33334335 |
| 36 | Muscle fiber inclusion bodies (HP:0100299) | 2.32980690 |
| 37 | Increased serum ferritin (HP:0003281) | 2.31272297 |
| 38 | Hyperacusis (HP:0010780) | 2.25953994 |
| 39 | Fatigue (HP:0012378) | 2.18448437 |
| 40 | Prolonged bleeding time (HP:0003010) | 2.13065171 |
| 41 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.07357531 |
| 42 | Autoimmune hemolytic anemia (HP:0001890) | 2.01194692 |
| 43 | Rectal prolapse (HP:0002035) | 2.01074076 |
| 44 | Osteomyelitis (HP:0002754) | 1.93450295 |
| 45 | Abnormality of the thoracic spine (HP:0100711) | 1.92888062 |
| 46 | Abnormal number of erythroid precursors (HP:0012131) | 1.92869506 |
| 47 | Toxemia of pregnancy (HP:0100603) | 1.91427297 |
| 48 | Orthostatic hypotension (HP:0001278) | 1.90162016 |
| 49 | Pelvic girdle muscle weakness (HP:0003749) | 1.88310805 |
| 50 | Recurrent viral infections (HP:0004429) | 1.87999383 |
| 51 | Hyperkalemia (HP:0002153) | 1.87394734 |
| 52 | Gastrointestinal carcinoma (HP:0002672) | 1.86306154 |
| 53 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.86306154 |
| 54 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.84829734 |
| 55 | Long palpebral fissure (HP:0000637) | 1.83778581 |
| 56 | Truncus arteriosus (HP:0001660) | 1.83001888 |
| 57 | Myoglobinuria (HP:0002913) | 1.81354690 |
| 58 | Gastrointestinal stroma tumor (HP:0100723) | 1.80785351 |
| 59 | Abnormality of the tricuspid valve (HP:0001702) | 1.80453018 |
| 60 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.78390597 |
| 61 | Distal lower limb muscle weakness (HP:0009053) | 1.76453853 |
| 62 | Achilles tendon contracture (HP:0001771) | 1.76011862 |
| 63 | Agammaglobulinemia (HP:0004432) | 1.75817152 |
| 64 | Pallor (HP:0000980) | 1.75304945 |
| 65 | Hypertriglyceridemia (HP:0002155) | 1.74608206 |
| 66 | Cutaneous photosensitivity (HP:0000992) | 1.74036929 |
| 67 | EMG: myopathic abnormalities (HP:0003458) | 1.73567749 |
| 68 | Hepatocellular carcinoma (HP:0001402) | 1.72038331 |
| 69 | Type 1 muscle fiber predominance (HP:0003803) | 1.71887211 |
| 70 | Slow saccadic eye movements (HP:0000514) | 1.71025185 |
| 71 | Difficulty climbing stairs (HP:0003551) | 1.70343568 |
| 72 | Dysmetric saccades (HP:0000641) | 1.69916426 |
| 73 | Viral hepatitis (HP:0006562) | 1.69839940 |
| 74 | Tetraparesis (HP:0002273) | 1.69739200 |
| 75 | Spontaneous hematomas (HP:0007420) | 1.69314635 |
| 76 | Ankyloglossia (HP:0010296) | 1.69297085 |
| 77 | Gastrointestinal infarctions (HP:0005244) | 1.67225570 |
| 78 | Myocardial infarction (HP:0001658) | 1.67206258 |
| 79 | Seborrheic dermatitis (HP:0001051) | 1.66854519 |
| 80 | Difficulty running (HP:0009046) | 1.63943273 |
| 81 | Uterine leiomyosarcoma (HP:0002891) | 1.63695704 |
| 82 | Leiomyosarcoma (HP:0100243) | 1.63695704 |
| 83 | Bowel incontinence (HP:0002607) | 1.62781938 |
| 84 | Epistaxis (HP:0000421) | 1.62609801 |
| 85 | Increased variability in muscle fiber diameter (HP:0003557) | 1.62379298 |
| 86 | Vertebral compression fractures (HP:0002953) | 1.61496647 |
| 87 | Increased mean platelet volume (HP:0011877) | 1.61477005 |
| 88 | Exercise-induced muscle cramps (HP:0003710) | 1.61371656 |
| 89 | Colitis (HP:0002583) | 1.60823419 |
| 90 | Long eyelashes (HP:0000527) | 1.60714215 |
| 91 | Thoracic kyphosis (HP:0002942) | 1.60573181 |
| 92 | Hyponatremia (HP:0002902) | 1.59027646 |
| 93 | Peripheral hypomyelination (HP:0007182) | 1.58544366 |
| 94 | Hypoparathyroidism (HP:0000829) | 1.58290849 |
| 95 | Gastrointestinal dysmotility (HP:0002579) | 1.57309142 |
| 96 | Abnormal large intestine physiology (HP:0012700) | 1.56541599 |
| 97 | Decreased motor nerve conduction velocity (HP:0003431) | 1.56288851 |
| 98 | Abnormal platelet volume (HP:0011876) | 1.55061364 |
| 99 | Abnormality of the Achilles tendon (HP:0005109) | 1.53412460 |
| 100 | Muscle fiber splitting (HP:0003555) | 1.53130577 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EIF2AK1 | 5.03885316 |
| 2 | PRPF4B | 3.66565216 |
| 3 | CDK12 | 3.07417856 |
| 4 | SMG1 | 2.75447282 |
| 5 | TAOK2 | 2.62720306 |
| 6 | ICK | 2.51081609 |
| 7 | TIE1 | 2.47200100 |
| 8 | MAP2K3 | 2.41584327 |
| 9 | SCYL2 | 2.17399571 |
| 10 | TRIB3 | 2.13345306 |
| 11 | IRAK3 | 2.05255793 |
| 12 | TAOK1 | 2.04518200 |
| 13 | PIM1 | 1.81983444 |
| 14 | MAP3K10 | 1.80589553 |
| 15 | BMX | 1.77409519 |
| 16 | STK4 | 1.75857805 |
| 17 | EEF2K | 1.71177679 |
| 18 | ERN1 | 1.67064078 |
| 19 | WNK1 | 1.57921501 |
| 20 | MAP3K11 | 1.43626694 |
| 21 | OBSCN | 1.31914990 |
| 22 | MAP3K8 | 1.31149503 |
| 23 | TTN | 1.27771327 |
| 24 | SIK1 | 1.27042534 |
| 25 | PBK | 1.25553680 |
| 26 | TRPM7 | 1.24374688 |
| 27 | MAP3K1 | 1.20379169 |
| 28 | CAMK1D | 1.14555981 |
| 29 | MTOR | 1.13172313 |
| 30 | CLK1 | 1.11904402 |
| 31 | IKBKE | 1.06073889 |
| 32 | KSR2 | 1.05377072 |
| 33 | MAP3K3 | 1.04074175 |
| 34 | RPS6KA5 | 1.03218265 |
| 35 | TTK | 1.01915371 |
| 36 | NEK9 | 1.00727257 |
| 37 | DYRK3 | 0.97088798 |
| 38 | TESK2 | 0.92202835 |
| 39 | TBK1 | 0.90832138 |
| 40 | MAP2K2 | 0.88693843 |
| 41 | KDR | 0.87422182 |
| 42 | MAPK11 | 0.86245141 |
| 43 | DYRK1B | 0.82422172 |
| 44 | GRK6 | 0.82288540 |
| 45 | HIPK2 | 0.78333191 |
| 46 | PIM2 | 0.78282541 |
| 47 | CDK4 | 0.76478453 |
| 48 | CHUK | 0.75995895 |
| 49 | RPS6KC1 | 0.74046073 |
| 50 | RPS6KL1 | 0.74046073 |
| 51 | CDK7 | 0.73353192 |
| 52 | PRKAA2 | 0.72410281 |
| 53 | NEK1 | 0.71749588 |
| 54 | MAP2K1 | 0.71127929 |
| 55 | RIPK4 | 0.70201333 |
| 56 | AKT2 | 0.69537274 |
| 57 | FGFR4 | 0.67648711 |
| 58 | PKN2 | 0.67638089 |
| 59 | MAP3K5 | 0.67476792 |
| 60 | ZAK | 0.67010003 |
| 61 | CDC7 | 0.64348188 |
| 62 | RPS6KB2 | 0.63160383 |
| 63 | MAP3K14 | 0.62376938 |
| 64 | SYK | 0.60692754 |
| 65 | CCNB1 | 0.60237940 |
| 66 | CDK6 | 0.60062132 |
| 67 | SGK3 | 0.58806073 |
| 68 | LATS2 | 0.58593932 |
| 69 | CHEK2 | 0.57297275 |
| 70 | CHEK1 | 0.57242492 |
| 71 | AURKA | 0.56872917 |
| 72 | MARK3 | 0.56161721 |
| 73 | AURKB | 0.55290384 |
| 74 | NEK2 | 0.54841092 |
| 75 | BRAF | 0.53946920 |
| 76 | NME2 | 0.52203139 |
| 77 | IKBKB | 0.51106950 |
| 78 | DAPK3 | 0.51054410 |
| 79 | RPS6KA2 | 0.49251313 |
| 80 | RPS6KA6 | 0.48771469 |
| 81 | KSR1 | 0.48748158 |
| 82 | VRK1 | 0.47889837 |
| 83 | BCKDK | 0.47053945 |
| 84 | LMTK2 | 0.45939781 |
| 85 | PRKAA1 | 0.45879101 |
| 86 | PLK1 | 0.45475396 |
| 87 | RAF1 | 0.44860756 |
| 88 | JAK3 | 0.44769601 |
| 89 | PLK3 | 0.43132969 |
| 90 | IRAK4 | 0.42651397 |
| 91 | ZAP70 | 0.42619388 |
| 92 | JAK2 | 0.42387669 |
| 93 | CDK9 | 0.40723572 |
| 94 | CAMK1G | 0.40546139 |
| 95 | MAPKAPK2 | 0.39998263 |
| 96 | MARK2 | 0.38321705 |
| 97 | CDK8 | 0.37079912 |
| 98 | LRRK2 | 0.36762143 |
| 99 | TAF1 | 0.36729868 |
| 100 | CDK2 | 0.34258963 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.49656820 |
| 2 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.58085657 |
| 3 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.34233890 |
| 4 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 2.34086029 |
| 5 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.18727819 |
| 6 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 2.03868008 |
| 7 | Bladder cancer_Homo sapiens_hsa05219 | 2.00238769 |
| 8 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.92858924 |
| 9 | DNA replication_Homo sapiens_hsa03030 | 1.87911505 |
| 10 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.85539480 |
| 11 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.72987742 |
| 12 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.68296454 |
| 13 | Cell cycle_Homo sapiens_hsa04110 | 1.62716998 |
| 14 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.62229249 |
| 15 | Thyroid cancer_Homo sapiens_hsa05216 | 1.61579603 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.60328508 |
| 17 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.53325386 |
| 18 | Alcoholism_Homo sapiens_hsa05034 | 1.52896293 |
| 19 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.52769259 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.47056908 |
| 21 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.46611011 |
| 22 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.46233059 |
| 23 | Endometrial cancer_Homo sapiens_hsa05213 | 1.44284277 |
| 24 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.36317503 |
| 25 | Apoptosis_Homo sapiens_hsa04210 | 1.31421943 |
| 26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.29680676 |
| 27 | Hepatitis B_Homo sapiens_hsa05161 | 1.28975684 |
| 28 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.24202342 |
| 29 | Carbon metabolism_Homo sapiens_hsa01200 | 1.23851635 |
| 30 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.23814377 |
| 31 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.20065988 |
| 32 | Mismatch repair_Homo sapiens_hsa03430 | 1.15430093 |
| 33 | Prostate cancer_Homo sapiens_hsa05215 | 1.14128898 |
| 34 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.14087055 |
| 35 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.13787446 |
| 36 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.12777837 |
| 37 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.12136846 |
| 38 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.10632891 |
| 39 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.08726878 |
| 40 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.08535271 |
| 41 | Shigellosis_Homo sapiens_hsa05131 | 1.08347726 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.03757420 |
| 43 | HTLV-I infection_Homo sapiens_hsa05166 | 1.03155205 |
| 44 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.98997976 |
| 45 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.98471931 |
| 46 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.94843854 |
| 47 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.94114542 |
| 48 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.93916736 |
| 49 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.93819255 |
| 50 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.93577188 |
| 51 | Spliceosome_Homo sapiens_hsa03040 | 0.93398524 |
| 52 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.92856243 |
| 53 | Influenza A_Homo sapiens_hsa05164 | 0.91931307 |
| 54 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.91661073 |
| 55 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.90880861 |
| 56 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.90328181 |
| 57 | Hepatitis C_Homo sapiens_hsa05160 | 0.89630974 |
| 58 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.88932434 |
| 59 | Measles_Homo sapiens_hsa05162 | 0.87465568 |
| 60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.87075126 |
| 61 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.86018964 |
| 62 | Insulin resistance_Homo sapiens_hsa04931 | 0.85944977 |
| 63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85689484 |
| 64 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.84612094 |
| 65 | Glioma_Homo sapiens_hsa05214 | 0.80679293 |
| 66 | Galactose metabolism_Homo sapiens_hsa00052 | 0.80588073 |
| 67 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.78445547 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.77854626 |
| 69 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.77756572 |
| 70 | Base excision repair_Homo sapiens_hsa03410 | 0.76898397 |
| 71 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.74964797 |
| 72 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.74533387 |
| 73 | RNA transport_Homo sapiens_hsa03013 | 0.74049344 |
| 74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73985046 |
| 75 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.73580978 |
| 76 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.72412157 |
| 77 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.71394509 |
| 78 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.71391014 |
| 79 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.68972502 |
| 80 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.66622959 |
| 81 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.65614383 |
| 82 | Adherens junction_Homo sapiens_hsa04520 | 0.65363229 |
| 83 | Colorectal cancer_Homo sapiens_hsa05210 | 0.62992979 |
| 84 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.60054682 |
| 85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59655902 |
| 86 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.59386352 |
| 87 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.59037399 |
| 88 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.58707083 |
| 89 | Leishmaniasis_Homo sapiens_hsa05140 | 0.58337472 |
| 90 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.58152393 |
| 91 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.56429780 |
| 92 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55721366 |
| 93 | Focal adhesion_Homo sapiens_hsa04510 | 0.55139884 |
| 94 | Melanoma_Homo sapiens_hsa05218 | 0.50573309 |
| 95 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49994460 |
| 96 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.49370500 |
| 97 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.46813071 |
| 98 | Other glycan degradation_Homo sapiens_hsa00511 | 0.46279194 |
| 99 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.43584396 |
| 100 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.41662725 |

